FibroGen, Inc. (FGEN)
8.48
+0.05
(+0.59%)
USD |
NASDAQ |
Dec 24, 12:59
8.48
0.00 (0.00%)
After-Hours: 13:59
FibroGen SG&A Expense (TTM): 28.80M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| Perspective Therapeutics, Inc. | 31.53M |
| Skye Bioscience, Inc. | 16.93M |
| Theravance Biopharma, Inc. | 75.94M |
| Myomo, Inc. | 32.71M |